Article
MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients.
BMC genetics - 13 Feb 2016
Reyes-Gibby Cielito C, Wang Jian, Silvas Mary Rose T, Yu Robert, Yeung Sai-Ching J, Shete Sanjay
Abstract excerpt
BACKGROUND: Genetic susceptibility plays an important role in the risk of developing pain in individuals with cancer. As a complex trait, multiple genes underlie this susceptibility. We used gene network analyses to identify novel target genes associated with pain in patients newly diagnosed with squamous cell carcinoma of the head and neck (HNSCC). RESULTS: We first identified 36 cancer pain-related genes (i.e.,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
